Aurora Spine received a Notice of Allowance from the USPTO, titled Spinal Implant for Motion Preservation or Fusion. This patent covers the ZIPFlex, a minimally invasive posterior non-fusion interspinous implant in development for motion preservation.
By employing a small attachment, the ZIPFlex spine implant can be converted to act as a fusion or non-fusion device.
Trent Northcutt, President and Chief Executive Officer, said, “We are delighted to receive this Notice of Allowance from the USPTO, as it demonstrates Aurora’s commitment to designing new technologies that not only differentiate us from other mainstream products on the marketplace but build upon the company’s intellectual property and patent portfolio. This patent will allow us to commercialize new products like the ZIPFlex and increase shareholder value.”
Aurora Spine received a Notice of Allowance from the USPTO, titled Spinal Implant for Motion Preservation or Fusion. This patent covers the ZIPFlex, a minimally invasive posterior non-fusion interspinous implant in development for motion preservation.
By employing a small attachment, the ZIPFlex spine implant can be converted to act as a fusion...
Aurora Spine received a Notice of Allowance from the USPTO, titled Spinal Implant for Motion Preservation or Fusion. This patent covers the ZIPFlex, a minimally invasive posterior non-fusion interspinous implant in development for motion preservation.
By employing a small attachment, the ZIPFlex spine implant can be converted to act as a fusion or non-fusion device.
Trent Northcutt, President and Chief Executive Officer, said, “We are delighted to receive this Notice of Allowance from the USPTO, as it demonstrates Aurora’s commitment to designing new technologies that not only differentiate us from other mainstream products on the marketplace but build upon the company’s intellectual property and patent portfolio. This patent will allow us to commercialize new products like the ZIPFlex and increase shareholder value.”
Copy to clipboard 
